SCHEMBL2668320

SCHEMBL2668320

CC(C)(Oc1ccc(O)c(O)c1)C(N)=O

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PPARA Q07869 5/20 0.40
▸ CYP1A2 P05177 3/20 0.40
▸ CYP3A4 P08684 3/20 0.40
▸ MAPT P10636 3/20 0.40
▸ MEN1 O00255 3/20 0.40
▸ KMT2A Q03164 3/20 0.40
▸ CYP2D6 P10635 1/20 0.40
▸ CYP2C19 P33261 1/20 0.40
▸ ALDH1A1 P00352 4/20 0.39
▸ HSD17B10 Q99714 4/20 0.39
▸ HPGD P15428 3/20 0.39
▸ ALOX15 P16050 3/20 0.39
▸ TDP1 Q9NUW8 3/20 0.39
▸ KDM4E B2RXH2 3/20 0.39
▸ POLB P06746 2/20 0.39
▸ USP2 O75604 1/20 0.39
▸ EGFR P00533 1/20 0.39
▸ FYN P06241 1/20 0.39
▸ GAA P10253 1/20 0.39
▸ APEX1 P27695 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2668282 0.77 PPARA (0.46) PPARACYP1A2CYP3A4MAPTMEN1
SCHEMBL11813157 0.77 CYP1A2 (0.46) PPARACYP1A2MAPTMEN1KMT2A
SCHEMBL1052285 0.77 ALDH1A1 (0.46) CYP1A2CYP3A4MAPTMEN1KMT2A
SCHEMBL7348145 0.76 PPARA (0.39) PPARACYP1A2CYP3A4MAPTMEN1
SCHEMBL4000649 0.76 PPARA (0.47) PPARACYP1A2CYP3A4MAPTMEN1
SCHEMBL3948925 0.76 PPARA (0.47) PPARACYP1A2CYP3A4MAPTMEN1
SCHEMBL4688589 0.74 PPARA (0.48) PPARACYP1A2CYP3A4MAPTMEN1
SCHEMBL3233909 0.74 KMT2A (0.47) PPARACYP1A2CYP3A4MAPTMEN1
SCHEMBL626124 0.74 PPARA (0.70) PPARACYP1A2CYP3A4MAPTMEN1
SCHEMBL18260725 0.74 PPARA (0.46) PPARACYP1A2CYP3A4MAPTMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2125735-B1 2,2,2-TRI-SUBSTITUTED ACETAMIDE DERIVATIVES AS GLUCOKINASE ACTIVATORS, THEIR PROCESS AND PHARMACEUTICAL APPLICATION ADVINUS THERAPEUTICS PRIVATE LTD (IN) 2012-06-27 — — EP disclosed
WO-2008104994-A2 2,2,2-TRI-SUBSTITUTED ACETAMIDE DERIVATIVES AS GLUCOKINASE ACTIVATORS, THEIR PROCESS AND PHARMACEUTICAL APPLICATION ADVINUS THERAPEUTICS PRIVATE LIMITED (IN) 2008-09-04 — — WO disclosed
Send feedback